Aquatic Capital Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4M Buy
+25,820
New +$2.43M 0.08% 319
2026
Q1
Sell
-20,793
Closed -$1.98M 1392
2025
Q4
$1.98M Buy
+20,793
New +$2.09M 0.06% 376
2025
Q3
Sell
-26,640
Closed -$2.84M 1397
2025
Q2
$2.84M Buy
26,640
+5,920
+29% +$598K 0.06% 378
2025
Q1
$1.89M Buy
+20,720
New +$2.32M 0.05% 429
2024
Q3
Sell
-44,400
Closed -$3.57M 1170
2024
Q2
$3.57M Buy
+44,400
New +$4.06M 0.13% 160
2023
Q3
Sell
-2,200
Closed -$237K 1265
2023
Q2
$237K Sell
2,200
-2,900
-57% -$326K 0.01% 624
2023
Q1
$635K Buy
+5,100
New +$700K 0.04% 362

Other funds holding BNTX

Aquatic Capital Management's BNTX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in BioNTech (BNTX) in Q2 2026: 25,820 shares worth $2.4M. The stake represents 0.08% of the portfolio and ranks #319 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in BNTX as recently as Q4 2025.

Aquatic Capital Management first reported a position in BNTX in Q1 2023 and has held it in 7 quarters since. The position peaked at $3.57M in Q2 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Aquatic Capital Management held 25,820 shares of BioNTech worth $2.4M as of Q2 2026.
  • BioNTech was a new Aquatic Capital Management position in Q2 2026.
  • BioNTech made up 0.08% of Aquatic Capital Management's portfolio in Q2 2026, its #319 holding.
  • Aquatic Capital Management first reported a position in BioNTech in Q1 2023 and has held it in 7 quarters since.
  • Aquatic Capital Management's BioNTech position peaked at $3.57M in Q2 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.